Pacific Biosciences of California Inc (NAS:PACB)
$ 1.86 0.06 (3.33%) Market Cap: 506.90 Mil Enterprise Value: 908.43 Mil PE Ratio: 0 PB Ratio: 1.03 GF Score: 62/100

Q2 2022 Pacific Biosciences of California Inc Earnings Call Transcript

Aug 03, 2022 / 09:00PM GMT
Release Date Price: $5.21 (+7.42%)
Operator

Welcome to the PacBio Second Quarter Fiscal Year 2022 Earnings Call. (Operator Instructions).

I'd like now to turn the conference over to Mr. Todd Friedman, Director of Investor Relations. Please, go ahead.

Todd Friedman
Pacific Biosciences of California, Inc. - Director of IR

Good afternoon, and welcome to PacBio's Second Quarter 2022 earnings Conference Call. Earlier today, we issued a press release outlining the financial results we will be discussing on today's call, a copy of which is available on the Investor's section of our website at www.pacb.com or as furnished on Form 8-K available on the Securities and Exchange Commission website, at www.sec.gov. With me today are: Christian Henry, President and Chief Executive Officer, and Susan Kim, Chief Financial Officer.

Before we begin, I'd like to remind you that on today's call, we will be making forward-looking statements, including statements regarding predictions,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot